Skip to main content
Have a personal or library account? Click to login
Possible Role of TGF – B Pathways in Schizophrenia / Moguća Uloga TTGF - B Signalnih Puteva U Shizofreniji Cover

Possible Role of TGF – B Pathways in Schizophrenia / Moguća Uloga TTGF - B Signalnih Puteva U Shizofreniji

EABR. Experimental and Applied Biomedical Research
Volume 17 (2016): Issue 1 (March 2016)
By: ,  ,  ,  ,   and    
Open Access
|Apr 2016
References

References

  1. 1. Kecmanović D. Shizofrenija. Psihijatrija, II prerađeno i dopunjeno izdanje, Medicinska knjiga Beograd- Zagreb, 1983; 355-408.
    Search in Google Scholar
  2. 2. Lewis S, Escalona R, Keith S. Phenomenology of Schizophrenia, Kaplan & Sadock’s comprehensive textbook of psychiatry, ninth edition, 2009; 1: 1433-1451.
    Search in Google Scholar
  3. 3. World Health Organization: International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, World Health Organization, Geneva, 1992.
    Search in Google Scholar
  4. 4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000.
    Search in Google Scholar
  5. 5. Möller HJ.Development of DSM-V and ICD-11: tendencies and potential of new classifications in psychiatry at the current state of knowledge. Psychiatry Clin Neurosci. 2009; 63(5): 595-612.
    Open DOISearch in Google Scholar
  6. 6. Monji A, Kato T, Kanba S. Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. Psychiatry and Clinical Neurosciences 2009; 63: 257-265.
    Open DOISearch in Google Scholar
  7. 7. Narayan S, Tang B, Head SR, Gilmartin TJ, Sutcliffe JG, Dean B, Thomas EA.Molecular profiles of schizophrenia in the CNS at different stages of illness. Brain Res. 2008; 1239: 235-48.
    Open DOISearch in Google Scholar
  8. 8. Yolken RH, Torrey EF. Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev. 1995; 8(1): 131-45.
    Open DOISearch in Google Scholar
  9. 9. Müller N, Riedel M, Gruber R, Manfred A. and Schwarz M. The Immune System and Schizophrenia- An Integrative View. Ann NY Acad Sci. 2000; 917: 456-67.
    Open DOISearch in Google Scholar
  10. 10. Cazzullo CL, Trabattoni D, Saresella M, Annoni G, Arosio B, Clerici M. Research on psychoimmunology. World J Biol Psychiatry. 2003; 4(3): 119-23.
    Open DOISearch in Google Scholar
  11. 11. Korn T, Anderson AC, Bettelli E, Oukka M. The dynamics of effector T cells and Foxp3+ regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis. J Neuroimmunol. 2007; 191(1-2): 51-60.
    Open DOISearch in Google Scholar
  12. 12. Abbas A, Lichtman AH, Pillai S. Cellular and Molecular Immunology, 6th Edition, Saunders, Elsevier, Philadelphia, USA, 2007.
    Search in Google Scholar
  13. 13. Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, Menon S, Clifford T, Hunte B, Lesley R, Muchamuel T, Hurst SD, Zurawski G, Leach MW, Gorman DM, Rennick DM. IL-25 induces IL-4, IL-5, and IL-13 and Th2- associated pathologies in vivo. Immunity. 2001; 15(6): 985-95.
    Open DOISearch in Google Scholar
  14. 14. Müller N, Schwarz MJ. Immune System and Schizophrenia. Curr Immunol Rev. 2010; 6(3): 213-220.
    Open DOISearch in Google Scholar
  15. 15. Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM, Fugger L. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol. 2008; 172(1): 146-55.
    Open DOISearch in Google Scholar
  16. 16. Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat Med 2007; 13: 139-145.
    Open DOISearch in Google Scholar
  17. 17. Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN. Regulatory T cells and human disease. Clin Dev Immunol. 2007; 2007: 89195.
    Open DOISearch in Google Scholar
  18. 18. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24: 179-189.
    Open DOISearch in Google Scholar
  19. 19. Schizophrenia: From the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers. World Journal of Biological Psychiatry 2009; 10(2): 127- 155.
    Open DOISearch in Google Scholar
  20. 20. Oertel-Knöchel V, Bittner RA, Knöchel C, Prvulovic D, Hampel H. Discovery and development of integrative biological markers for schizophrenia. Prog Neurobiol. 2011; 95(4): 686-702.
    Open DOISearch in Google Scholar
  21. 21. Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects. Biol Psychiatry. 2011; 70(7): 663-71.
    Open DOISearch in Google Scholar
  22. 22. Borovcanin M, Jovanovic I, Radosavljevic G, Djukic Dejanovic S, Bankovic D, Arsenijevic N, Lukic ML. Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse. J Psychiatr Res. 2012; 46(11): 1421-6.
    Open DOISearch in Google Scholar
  23. 23. Borovcanin M, Jovanovic I, Radosavljevic G, Djukic Dejanovic S, Stefanovic V, Arsenijevic N, Lukic ML. Antipsychotics can modulate the cytokine profile in schizophrenia: attenuation of the type-2 inflammatory response. Schizophr Res. 2013; 147(1): 103-9.
    Open DOISearch in Google Scholar
  24. 24. Borovcanin M, Jovanovic I, Radosavljevic G, Djukic Dejanovic S, Stefanovic V, Arsenijevic N, Lukic ML. Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia. Psychoneuroendocrinology. 2015; 56: 143-7.
    Open DOISearch in Google Scholar
  25. 25. Curfs JH, Meis JF, Hoogkamp-Korstanje JA. A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev. 1997; 10(4): 742-80.
    Open DOISearch in Google Scholar
  26. 26. Moustakas A, Pardali K, Gaal A, Heldin CH. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol Lett. 2002; 82 (1-2): 85-91.
    Open DOISearch in Google Scholar
  27. 27. Coomes SM, Moore BB. Pleiotropic effects of transforming growth factor-β in hematopoietic stem-cell transplantation.Transplantation. 2010; 90 (11): 1139-44.
    Open DOISearch in Google Scholar
  28. 28. Yoshimura A, Wakabayashi Y, Mori T. Cellular and molecular basis for the regulation of inflammation by TGF-beta. J Biochem. 2010; 147(6): 781-92.
    Open DOISearch in Google Scholar
  29. 29. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-8.
    Open DOISearch in Google Scholar
  30. 30. Mangan PR, Harrington LE, O’Quinn DB, Helms WS, Bullard DC, Elson CO, et al. Transforming growth factor-β induces development of the TH17 lineage. Nature 2006; 441: 231-4.
    Open DOISearch in Google Scholar
  31. 31. Massague J. TGF beta signaling: receptors, transducers, and Mad proteins. Cell. 1996; 85: 947-950.
    Open DOISearch in Google Scholar
  32. 32. Krieglstein K, Zheng F, Unsicker K, Alzheimer C. More than being protective: functional roles for TGF-β/activin signaling pathways at central synapses. Trends Neurosci. 2011; 3 4(8): 421-9.
    Open DOISearch in Google Scholar
  33. 33. Sun M, Gewirtz JC, Bofenkamp L, Wickham RJ, Ge H, O’Connor MB. Canonical TGF-beta signaling is required for the balance of excitatory/inhibitory transmission within the hippocampus and prepulse inhibition of acoustic startle. J Neurosci. 2010; 30(17): 6025-35.
    Open DOISearch in Google Scholar
  34. 34. Tesseur I, Zou K, Esposito L, Bard F, Berber E, Can JV, Lin AH, Crews L, Tremblay P, Mathews P, Mucke L, Masliah E, Wyss-Coray T. Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer’s pathology. J Clin Invest. 2006; 116: 3060-9.
    Open DOISearch in Google Scholar
  35. 35. Ueberham U, Ueberham E, Gruschka H, Arendt T. Altered subcellu- lar location of phosphorylated Smads in Alzheimer’s disease. Eur J Neurosci. 2006; 24: 2327-2334.
    Open DOISearch in Google Scholar
  36. 36. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu FL, Myers LA, Spevak PJ, Cameron DE, De Backer J, Hellemans J, Chen Y, Davis EC, Webb CL, Kress W, Coucke P, Rifkin DB, De Paepe AM, Dietz HC. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005; 37: 275-281.
    Open DOISearch in Google Scholar
  37. 37. Frydecka D, Misiak B, Pawlak-Adamska E, Karabon L,Tomkiewicz A,Sedlaczek P,Kiejna A,Beszłej JA. Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia. Neuropsychiatr Dis Treat.2015; 11: 575-84.
    Search in Google Scholar
  38. 38. Benes FM, Lim B, Matzilevich D, Walsh JP, Subburaju S, Minns M. Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc Natl Acad Sci U S A. 2007; 104: 10164-9.
    Open DOISearch in Google Scholar
  39. 39. Dow AL, Russell DS, Duman RS. Regulation of activin mRNA and Smad2 phosphorylation by antidepressant treatment in the rat brain: effects in behavioral models. J Neurosci. 2005; 25: 4908-16.
    Open DOISearch in Google Scholar
  40. 40. Ageta H, Murayama A, Migishima R, Kida S, Tsuchida K, Yokoyama M, Inokuchi K. Activin in the brain modulates anxiety-related behavior and adult neurogenesis. PLoS One. 2008; 3(4): e1869.
    Open DOISearch in Google Scholar
  41. 41. Zheng F, Adelsberger H, Müller MR, Fritschy JM, Werner S, Alzheimer C. Activin tunes GABAergic neurotransmission and modulates anxiety-like behavior. Mol Psychiatry. 2009; 14: 332-346.
    Open DOISearch in Google Scholar
  42. 42. Kitazawa K, Tada T. Elevation of transforming growth factor-beta 1 level in cerebrospinal fluid of patients with communicating hydrocephalus after subarachnoid hemorrhage. Stroke. 1994; 25(7): 1400-4.
    Open DOISearch in Google Scholar
  43. 43. Mogi M, Harada M, Kondo T, Narabayashi H, Riederer P, Nagatsu T. Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson’s disease. Neurosci Lett. 1995; 193(2): 129-32.
    Open DOISearch in Google Scholar
  44. 44. Peterson PK, Chao CC, Hu S, Thielen K, Shaskan EG. Glioblastoma, transforming growth factor-beta, and Candida meningitis: a potential link. Am J Med. 1992; 92(3): 262-4.
    Open DOISearch in Google Scholar
  45. 45. Vawter MP, Dillon-Carter O, Issa F, Wyatt RJ, Freed WJ. Transforming growth factors beta 1 and beta 2 in the cerebrospinal fluid of chronic schizophrenic patients. Neuropsychopharmacology. 1997; 16(1): 83-7
    Open DOISearch in Google Scholar
  46. 46. Drexhage RC, Hoogenboezem TA, Cohen D, Versnel MA, Nolen WA, van Beveren NJ, Drexhage HA. An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces. Int J Neuropsychopharmacol. 2011; 14(6): 746-55.
    Open DOISearch in Google Scholar
  47. 47. Kim YK, Myint AM, Lee BH, Han CS, Lee HJ, Kim DJ, Leonard BE. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2004; 28(7): 1129-34.
    Open DOISearch in Google Scholar
  48. 48. Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Hashimoto R, Takeda M, Kunugi H, Itakura M, Ohmori T. TGFBR2 gene expression and genetic association with schizophrenia. J Psychiatr Res. 2008; 42(6): 425-32.
    Open DOISearch in Google Scholar
  49. 49. Meyer U, Schwarz MJ, Müller N. Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Pharmacol Ther. 2011; 132(1): 96-110.
    Open DOISearch in Google Scholar
  50. 50. El Kissi Y, Samoud S, Mtiraoui A, Letaief L, Hannachi N, Ayachi M, Ali BB, Boukadida J. Increased Interleukin-17 and decreased BAFF serum levels in drug-free acute schizophrenia. Psychiatry Res. 2015; 225(1-2): 58-63.
    Open DOISearch in Google Scholar
  51. 51. Dimitrov DH, Lee S, Yantis J, Valdez C, Paredes RM, Braida N, Velligan D, Walss-Bass C. Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: potential role for IL-17 pathway. Schizophr Res. 2013; 151 (1-3): 29-35.
    Open DOISearch in Google Scholar
  52. 52. Ding M, Song X, Zhao J, Gao J, Li X, Yang G, Wang X, Harrington A, Fan X, Lv L. Activation of Th17 cells in drug naïve, first episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry.2014; 51: 78-82.
    Open DOISearch in Google Scholar
  53. 53. Tourjman V, Kouassi É, Koué MÈ, Rocchetti M, Fortin- Fournier S, Fusar-Poli P, Potvin S. Antipsychotics’ effects on blood levels of cytokines in schizophrenia: a meta-analysis. Schizophr Res. 2013; 151(1-3): 43-7.
    Open DOISearch in Google Scholar
  54. 54. Jia P, Wang L, Meltzer HY, Zhao Z. Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. Schizophr Res. 2010; 122(1-3): 38-42.
    Open DOISearch in Google Scholar
  55. 55. Frydecka D, Misiak B, Beszlej JA, Karabon L, Pawlak- Adamska E, Tomkiewicz A, Partyka A, Jonkisz A, Kiejna A. Genetic variants in transforming growth factor-_ gene (TGFB1) affect susceptibility to schizophrenia. Mol Biol Rep. 2013; 40(10): 5607-14.
    Open DOISearch in Google Scholar
  56. 56. Falk S, Wurdak H, Ittner LM, Ille F, Sumara G, Schmid MT, Draganova K, Lang KS, Paratore C, Leveen P, Suter U, Karlsson S, Born W, Ricci R, Gotz M, Sommer L. Brain areaspecific effect of TGF-beta signaling on Wntdependent neural stem cell expansion. Cell Stem Cell. 2008; 2(5): 472-483.
    Open DOISearch in Google Scholar
  57. 57. Yirmiya R, Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun. 2011; 25(2): 181-213.
    Open DOISearch in Google Scholar
  58. 58. Kalkman HO. Altered growth factor signaling pathways as the basis of aberrant stem cell maturation in schizophrenia. Pharmacol Ther. 2009; 121(1): 115-22.
    Open DOISearch in Google Scholar
  59. 59. Krieglstein K, Suter-Crazzolara C, Fischer WH, Unsicker K. TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J. 1995; 14(4): 736-742.
    Open DOISearch in Google Scholar
  60. 60. Mathieu P, Piantanida AP, Pitossi F. Chronic expression of transforming growth factor-beta enhances adult neurogenesis. Neuroimmunomodulation. 2010; 17(3): 200-1.
    Open DOISearch in Google Scholar
  61. 61. Dobolyi A, Vincze C, Pal G, Lovas G. The neuroprotective functions of transforming growth factor beta proteins. Int J Mol Sci 2012; 13(7): 8219- 58.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/sjecr-2015-0038 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Journal RSS Feed
Language: English
Page range: 3 - 8
Submitted on: Oct 20, 2014
Published on: Apr 14, 2016
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Keywords:
schizophrenia,
biomarkers,
TGF-β,
neuroplasticity
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2016 Milica Borovcanin, Ivan Jovanovic, Slavica Djukic Dejanovic, Gordana Radosavljevic, Nebojsa Arsenijevic, Miodrag L. Lukic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 17 (2016): Issue 1 (March 2016)
Next article